Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$189K Sell
30,742
-1,893
-6% -$12.8K 0.24% 50
2025
Q2
$176K Sell
32,635
-45,745
-58% -$321K 0.23% 49
2025
Q1
$597K Buy
78,380
+123
+0.2% +$1.06K 0.9% 34
2024
Q4
$758K Buy
78,257
+3,257
+4% +$33.8K 0.75% 31
2024
Q3
$894K Buy
75,000
+6,875
+10% +$97.2K 1.13% 25
2024
Q2
$1.09M Sell
68,125
-14,375
-17% -$222K 1.45% 18
2024
Q1
$970K Buy
82,500
+13,700
+20% +$194K 0.95% 25
2023
Q4
$1.23M Buy
68,800
+39,451
+134% +$579K 1.1% 20
2023
Q3
$535K Sell
29,349
-1,901
-6% -$45.4K 0.59% 26
2023
Q2
$738K Hold
31,250
0.84% 23
2023
Q1
$750K Buy
+31,250
New +$415K 0.86% 21

Other funds holding SCYX

AMH Equity's SCYX Position: Q3 2025 in Review

AMH Equity reduced its SCYNEXIS (SCYX) stake by 5.8% in Q3 2025, selling an estimated $12.8K and leaving 30,742 shares worth $189K. The position accounts for 0.24% of the portfolio, ranked #50.

AMH Equity first reported a position in SCYX in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.23M in Q4 2023. 43 funds tracked by Wall St. Rank hold SCYX as of Q3 2025.

  • AMH Equity held 30,742 shares of SCYNEXIS worth $189K as of Q3 2025.
  • AMH Equity sold 1,893 SCYNEXIS shares in Q3 2025, an estimated $12.8K.
  • SCYNEXIS made up 0.24% of AMH Equity's portfolio in Q3 2025, its #50 holding.
  • AMH Equity first reported a position in SCYNEXIS in Q1 2023 and has held it in 11 quarters since.
  • AMH Equity's SCYNEXIS position peaked at $1.23M in Q4 2023.
  • 43 funds tracked by Wall St. Rank held SCYNEXIS as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.